PharmiWeb.com - Global Pharma News & Resources
28-Jan-2019

Critical Limb Ischemia Pipeline Insights, 2019 - ResearchAndMarkets.com

The "Critical Limb Ischemia - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

"Critical Limb Ischemia - Pipeline Insight, 2019 report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Critical Limb Ischemia development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

The report assesses the active Critical Limb Ischemia pipeline products by developmental stage, product type, molecule type, and administration route.

Key Topics Covered:

1. Report Introduction

2. Critical Limb Ischemia Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for Critical Limb Ischemia

4. Comparative Analysis

5. Products in Clinical Stage

  • Product Description
  • Research and Development
  • Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment

  • Assessment by Route of Administration
  • Assessment by Stage and Route of Administration
  • Assessment by Molecule Type
  • Assessment by Stage and Molecule Type

8. Inactive Products

  • Product Description
  • Research and Development
  • Product Development Activities

Companies Mentioned

  • Cesca Therapeutics Inc.
  • Pluristem Ltd.
  • Rexgenero Limited
  • Boston Scientific Corporation
  • Hemostemix
  • Caladrius Biosciences Inc.
  • Reven Pharmaceuticals Inc.
  • BioGenCell Ltd.
  • Pharmicell Co. Ltd.
  • Proteon Therapeutics
  • AnGes MG Inc
  • Apceth Biopharma GmbH
  • Athersys Inc
  • BiogenCell Ltd
  • Caladrius Biosciences Inc
  • Cynata Therapeutics Ltd

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/2fp2cx/critical_limb?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190128005368/en/

Editor Details

Last Updated: 28-Jan-2019